Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium

Arthritis and Rheumatism

Volumn 46, Issue 3, 2002, Pages 663-674

  Hou, Wu Shiun ^a   Li, Weijie ^a   Keyszer, Gernot ^b   Weber, Ekkehard ^b   Levy, Roger ^a   Klein, Michael J ^a   Gravallese, Ellen M ^c   Goldring, Steven R ^c   Brömme, Dieter ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; CATHEPSIN S; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

ADULT; ANTIGEN PRESENTATION; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERDIGITATING CELL; MALE; NORTHERN BLOTTING; OSTEOARTHRITIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; WESTERN BLOTTING;

ARTHRITIS, RHEUMATOID; CATHEPSINS; CELLS, CULTURED; ENDOPEPTIDASES; FEMALE; HUMANS; INTERLEUKIN-1; JOINTS; MALE; MIDDLE AGED; OSTEOARTHRITIS; RNA, MESSENGER; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036185401     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10114     Document Type: Article

References (49)

1. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: Passive responders or transformed aggressors?
2. Etiology and pathogenesis of rheumatoid arthritis
3. The possible role of c-fos expression in rheumatoid cartilage destruction
4. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint
5. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis
6. The role of the chondrocyte in osteoarthritis
7. Proteinases and matrix degradation
8. Cysteine proteases as therapeutic targets
9. Metalloproteinase inhibitors and the prevention of connective tissue breakdown
10. Future directions for research and treatment of osteoarthritis
11. Thirty-six years in the clinic without an MMP inhibitor: What hath collagenase wrought?
12. Emerging roles for cysteine proteases in human biology
13. Cathepsin K and the design of inhibitors of cathepsin K
14. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency
15. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates
16. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues
17. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction
18. Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts
19. Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts
20. Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor α and interleukin-1
21. Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells
22. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading
23. Proteases involved in MHC class II antigen presentation
24. Cathepsin S from bovine spleen: Purification, distribution, intracellular localization and action on proteins
25. Functional expression of human cathepsin S in Saccharomyces cerevisiae: Purification and characterization of the recombinant enzyme
26. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
27. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee
28. The half-life of human procathepsin S
29. Quantitative analysis of synovial membrane inflammation: A comparison between automated and conventional microscopic measurements
30. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor
31. Localization of rat cathepsin K in osteoclasts and resorption pits: Inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones
32. Vinyl sulfones as mechanism-based cysteine protease inhibitors
33. Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2
34. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages
35. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts: Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme
36. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts
37. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin- K-deficient mice
38. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice
39. Control of matrix synthesis in isolated bovine chondrocytes by extracellular and intracellular pH
40. Metabolic activation stimulates acid production in synovial fibroblasts
41. Autocatalytic activation of cathepsin K
42. Inhibition of cysteine proteinases in lysosomes and whole cells
43. Phagocytosis and intracellular digestion of collagen, its role in turnover and remodeling
44. Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation
45. Cathepsin S required for normal MHC class II peptide loading and germinal center development
46. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix
47. The collagenolytic activity of cathepsin K is unique among mammalian proteinases
48. 4′-hydroxy aceclofenac suppresses the interleukin-1-induced production of promatrix metalloproteinases and release of sulfated-glycosaminoglycans from rabbit articular chondrocytes
49. Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis